RAIN - Rain Therapeutics EPS misses by $0.19 November, 10 2021 09:04 AM Rain Therapeutics Inc. Rain Therapeutics (NASDAQ:RAIN): Q3 GAAP EPS of -$0.70 misses by $0.19. Cash, cash equivalents and short-term investments of $150.08M Press Release For further details see: Rain Therapeutics EPS misses by $0.19